YOLFTbeta
AD

Adiuvo Investment SA

ADV · WAR · Healthcare / Medical Devices

0.576PLN-0.01 (-1.71%)

Price History

Full chart

Market Stats

Previous Close0.586
Open0.56
Day Range0.552 – 0.58
52-Week Range0.391 – 0.946
Volume22.67K
Market Cap7.98M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.32
Dividend Yield0.00%
Beta0.24
50-Day Avg0.5592
200-Day Avg0.5582

About

Adiuvo Investments S.A. is a venture capital firm specializing in incubation, seed, startup, early venture, and growth capital investments. The firm primarily invests in projects in the segment of medical devices, biomedical, life-science, digital health, technologies and nutraceuticals including functional food. It seeks to invest in Poland. It prefers to hold its investments from three up to five years. The firm makes balance sheet investments. Adiuvo Investment S.A. was founded in 2013 and is based in Warsaw, Poland.

Company Details

Leadership

  • Mr. Marek Jan Orlowski M.D.Founder & President of the Management Board · b. 1969
  • Ms. Anna Aranowska-BablokMember of Management Board

Financials

Income Statement

Currency: PLN2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-36.00K3.94M4.78M5.76M2.79M1.78M942.00K1.60M173.00K990.00K334.00K812.00K
Growth (%)--+10836.11%+21.39%+20.57%-51.51%-36.36%-47.02%+70.28%-89.21%+472.25%-66.26%+143.11%
Cost of Revenue16.00K2.79M2.54M3.47M3.39M1.42M645.00K291.00K939.00K223.00K7.00K14.00K2.65M
Gross Profit-16.00K-2.76M1.39M1.31M2.37M1.38M1.13M651.00K665.00K-50.00K983.00K320.00K-1.84M
Gross Margin--7655.56%35.36%27.43%41.17%49.36%63.72%69.11%41.46%-28.90%99.29%95.81%-226.48%
Operating Expense2.70M9.10M15.65M21.05M32.23M27.92M12.24M8.18M7.83M7.27M6.05M3.59M-316.00K
Operating Income-2.72M-11.86M-14.25M-19.73M-29.85M-26.54M-11.11M-7.53M-7.17M-7.32M-5.07M-3.27M-1.52M
Operating Margin--32933.33%-362.05%-412.93%-518.12%-949.79%-624.69%-799.15%-446.76%-4230.06%-512.32%-979.34%-187.56%
EBITDA-2.72M-11.53M-17.29M-18.44M-52.52M-23.42M-14.76M-12.88M-14.53M-42.72M-11.05M-1.28M-613.00K
EBITDA Margin--32019.44%-439.04%-385.94%-911.44%-838.30%-830.03%-1367.30%-905.55%-24690.75%-1116.46%-383.83%-75.49%
Net Income-3.14M1.72M-17.96M-17.20M-52.56M-27.21M-17.21M-13.01M-17.34M-57.90M-10.84M-2.79M-1.57M
Net Income Margin-4786.11%-456.29%-359.82%-912.22%-973.80%-968.05%-1381.00%-1080.92%-33465.90%-1094.95%-834.73%-193.47%
R&D1.69M-5.10M4.60M11.40M1.81M740.00K5.30M12.28M37.60M---
R&D as % of Total Revenue--129.54%96.25%197.85%64.71%41.62%562.85%765.34%21732.37%---
Interest Expense-1.49M1.01M702.00K1.56M679.00K695.00K1.12M1.76M4.84M2.75M739.00K1.69M
Interest Expense % of Total Revenue-4147.22%25.76%14.69%27.00%24.30%39.09%118.90%109.73%2795.38%277.98%221.26%208.37%

Balance Sheet

Currency: PLN2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets16.84M53.92M86.12M97.64M66.93M82.75M75.92M71.03M56.61M8.18M2.21M596.00K10.60M
Total Liabilities12.50M20.92M25.27M20.75M15.37M28.76M29.21M42.03M49.31M55.58M46.93M35.34M45.81M
Total Equity3.83M18.69M47.63M57.96M36.64M38.04M35.47M21.72M241.00K-51.82M-49.43M-33.40M-34.97M
Cash2.30M1.86M14.11M9.55M3.70M1.45M783.00K2.33M52.00K71.00K641.00K95.00K21.00K
Total Debt10.32M9.69M9.80M4.94M2.40M4.88M10.15M27.25M30.42M36.44M23.56M21.86M27.28M
Net Debt8.01M7.83M-4.31M-4.61M-1.30M3.42M9.37M24.92M30.37M36.37M22.92M21.77M27.26M

Cash Flow

Currency: PLN2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.60M-8.90M-18.00M-20.27M-32.33M-14.56M-4.31M-9.36M-5.78M-7.62M-4.98M-3.42M-376.00K
Investing Cash Flow765.33K-11.07M-14.07M-15.88M6.14M-7.97M-8.48M-5.93M-1.26M-130.00K106.00K3.11M-846.00K
Financing Cash Flow4.37M19.53M44.30M31.55M20.53M20.38M12.14M16.79M4.38M7.75M5.43M-232.00K1.14M
Capital Expenditure202.67K240.00K827.00K11.29M9.71M3.98M6.72M5.01M41.00K134.00K6.00K7.00K846.00K
Free Cash Flow-3.81M-9.14M-18.82M-31.56M-42.04M-18.54M-11.03M-14.37M-5.82M-7.75M-4.99M-3.42M-1.22M
FCF to OCF105.62%102.70%104.60%155.68%130.03%127.30%256.13%153.56%100.71%101.76%100.12%100.20%325.00%

Earnings

Report DateAug 14, 2015Nov 16, 2015Mar 22, 2016May 16, 2016Aug 31, 2016Nov 14, 2016Dec 31, 2016May 26, 2017Sep 18, 2017Nov 27, 2017Dec 31, 2017Apr 27, 2018Jun 30, 2018Nov 21, 2018Dec 31, 2018May 2, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Mar 31, 2026
EPS Estimate-----------------------------------------
EPS Actual-0.39-0.43-0.63-0.34-0.53-0.45-0.46-0.41-0.54-0.65-2.34-0.55-0.16-0.46-0.910.02-0.49-0.15-0.33-0.24-0.06-0.17-0.51-0.08-1.02-0.330.11-0.04-0.22-0.51-0.05-0.23-0.07-0.49-0.080.150.200.05-0.05-0.09-0.11
Surprise-----------------------------------------
TimingPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursPre-marketPre-market-After-hours-After-hours-Pre-market-------------------------

Key Statistics & Ratios

Market Cap7.98M
Enterprise Value33.18M
Trailing P/E0.00
Forward P/E0.00
Price / Sales18.52
Price / Book40.21
EPS-0.32
Book Value-2.76
Revenue (TTM)431.00K
Gross Profit (TTM)384.00K
EBITDA-2.54M
Profit Margin0.00%
Operating Margin-1984.78%
Return on Equity-332.89%
Return on Assets-13.35%
Shares Outstanding13.17M
Shares Float4.51M
Beta0.24
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%